Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Alimera Sciences Inc. (ALIM)

6.43   -0.33 (-4.88%) 02-14 16:00
Open: 6.5127 Pre. Close: 6.76
High: 6.57 Low: 6.42
Volume: 4,264 Market Cap: 32M
Alimera Sciences Inc is a biopharmaceutical company which is engaged in the research, development, and commercialization of ophthalmic pharmaceuticals.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.585 - 6.618 6.618 - 6.644
Low: 6.33 - 6.374 6.374 - 6.41
Close: 6.369 - 6.435 6.435 - 6.489

Technical analysis

as of: 2020-02-14 4:26:28 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 8.59     One year: 9.39
Support: Support1: 6.25    Support2: 5.20
Resistance: Resistance1: 7.36    Resistance2: 8.04
Pivot: 6.72
Moving Average: MA(5): 6.50     MA(20): 6.86
MA(100): 4.72     MA(250): 2.39
MACD: MACD(12,26): -0.11     Signal(9): -0.05
Stochastic oscillator: %K(14,3): 13.98     %D(3): 15.44
RSI: RSI(14): 43.56
52-week: High: 9.98  Low:   Change(%): 500.9
Average Vol(K): 3-Month: 5380  10-Days: 869

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ALIM has closed above bottom band by 16.8%. Bollinger Bands are 64.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to ALIM's normal range. The bands have been in this narrow range for 13 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Alimera Sciences Refinances Debt Facility With Solar Capital
Alimera announced it has entered into a new US$45 million term loan agreement with investment affiliates managed by Solar Capital Partners. The post Alimera Sciences Refinances Debt Facility With Solar Capital appeared first on Investing News Network .

Alimera Sciences Announces Board’s Approval of Reverse Stock Split Ratio
Alimera Sciences, Inc. (ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that it will effect a one-for-15 reverse stock split (reverse split) of its common stock that will become effective on

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 4.96
Shares Float (M) 2.78
% Held by Insiders 17.69
% Held by Institutions 56.59
Shares Short (K) 90
Shares Short P. Month (K)

Stock Financials

EPS -2.550
Book Value (p.s.) -7.780
PEG Ratio
Profit Margin -23.40
Operating Margin -11.58
Return on Assets (ttm) -7.7
Return on Equity (ttm)
Qtrly Rev. Growth 15.4
Gross Profit (p.s.) 8.526
Sales Per Share
EBITDA (p.s.) -0.675
Qtrly Earnings Growth
Operating Cash Flow (M) -3.91
Levered Free Cash Flow (M) 0.78

Stock Valuations

P/E -2.52
P/E Growth Ratio -0.02
P/BV -0.83
P/S 0.58
P/CF -8.16

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2019-11-14
Last Split Ratio 0.067
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.